This is a preview of subscription content, log in via an institution to check access.
Reference
Laviv Y, et al. Extremely late wound dehiscence following bevazicumab treatment in a long term survival glioblastoma patient. Clinical Neurology and Neurosurgery 127: 125-127, Dec 2014 - Israel
Rights and permissions
About this article
Cite this article
Bevazicumab. Reactions Weekly 1552, 41 (2015). https://doi.org/10.1007/s40278-015-0837-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-0837-x